{"altmetric_id":6042789,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"total":{"posts_count":11},"twitter":{"unique_users_count":11,"unique_users":["VinayPrasad82","Amy_Sharpton","SpaceMedic","gedefo_sefh","FarmaOnco","medicineupdate","DrChoueiri","SMarsh7818","DanaFarber","xianmeyer","dinasalah255"],"posts_count":11}},"selected_quotes":["Interesting article Treatment of Advanced Renal-Cell Carcinoma (via #pubmedontap)","Treatment of Advanced Renal-Cell Carcinoma #Massachusetts Medical Society: New England Journal of Medicine: Table \u2026","Does any oncologist have more first or last phase 3 papers than Robert Motzer does in RCC?"],"citation":{"abstract":"To the Editor: In their article on the CheckMate 025 trial, Motzer and colleagues (Nov. 5 issue)(1) report that nivolumab, as compared with everolimus, prolonged survival among patients with previously treated advanced renal-cell carcinoma. This trial opens the era of checkpoint inhibitors in renal-cell carcinoma and could help determine the most effective treatment sequence. Sunitinib and pazopanib are multitargeted tyrosine kinase inhibitors and first-line options that have similar efficacy.(2) However, with nivolumab as second-line treatment, they may not be equivalent. Indeed, the mechanism of efficacy of tyrosine kinase inhibitors in renal-cell carcinoma is still largely unknown and may not rely .\u00a0.\u00a0.","altmetric_jid":"4f6fa50e3cf058f6100031c4","authors":["Motzer, Robert J","Escudier, Bernard","Choueiri, Toni K"],"doi":"10.1056\/nejmc1515613","first_seen_on":"2016-03-02T23:04:53+00:00","funders":["niehs"],"issns":["1533-4406","0028-4793"],"issue":"9","journal":"New England Journal of Medicine","last_mentioned_on":1458289593,"links":["http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMc1515613","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMc1515613?af=R&rss=currentIssue","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26962911?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26962911?dopt=Citation"],"pmid":"26962911","pubdate":"2016-03-11T22:00:33+00:00","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["medicine"],"title":"Treatment of Advanced Renal-Cell Carcinoma.","type":"article","volume":"374","mendeley_url":"http:\/\/www.mendeley.com\/research\/treatment-advanced-renalcell-carcinoma-7"},"altmetric_score":{"score":5.2,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":5.2},"context_for_score":{"all":{"total_number_of_other_articles":8319279,"mean":7.0117334064249,"rank":1571285,"this_scored_higher_than_pct":81,"this_scored_higher_than":6740569,"rank_type":"exact","sample_size":8319279,"percentile":81},"similar_age_3m":{"total_number_of_other_articles":288389,"mean":10.998104969693,"rank":69349,"this_scored_higher_than_pct":75,"this_scored_higher_than":218640,"rank_type":"exact","sample_size":288389,"percentile":75},"this_journal":{"total_number_of_other_articles":20177,"mean":48.726870836638,"rank":11011,"this_scored_higher_than_pct":45,"this_scored_higher_than":9159,"rank_type":"exact","sample_size":20177,"percentile":45},"similar_age_this_journal_3m":{"total_number_of_other_articles":374,"mean":208.25384986595,"rank":281,"this_scored_higher_than_pct":24,"this_scored_higher_than":93,"rank_type":"exact","sample_size":374,"percentile":24}}},"demographics":{"poster_types":{"member_of_the_public":9,"practitioner":2},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":2,"Members of the public":9}},"mendeley":{"by_status":{"Student  > Ph. D. Student":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":1,"Unspecified":1}}},"geo":{"twitter":{"US":4,"KR":1,"ES":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/VinayPrasad82\/statuses\/705157616658296832","license":"gnip","citation_ids":[6042789],"posted_on":"2016-03-02T22:27:31+00:00","author":{"name":"Vinay Prasad","url":"http:\/\/vinayakkprasad.com","image":"https:\/\/pbs.twimg.com\/profile_images\/874283904584138754\/SKCzllHj_normal.jpg","description":"#researchparasite interested in policy, heme-onc, EBM & medical reversal; Specialize in lymphoma; Author of: https:\/\/t.co\/8mRKay1ufn\nFunded by @LJA_Foundation","id_on_source":"VinayPrasad82","tweeter_id":"1194962714","geo":{"lt":45.52345,"ln":-122.67621,"country":"US"},"followers":8596},"tweet_id":"705157616658296832"},{"url":"http:\/\/twitter.com\/Amy_Sharpton\/statuses\/705324714659614720","license":"gnip","citation_ids":[6042789],"posted_on":"2016-03-03T09:31:30+00:00","author":{"name":"Entrepreneur","url":"http:\/\/about.me\/amysharpton","image":"https:\/\/pbs.twimg.com\/profile_images\/735079205755604993\/K9Wqcyli_normal.jpg","description":"Entrepreneur; Strategic Partnerships Mgr; Social Connector; Pit Bull lover; Sports nut; Lyme patient; Fledgling musician; Author; Pub Speaker","id_on_source":"Amy_Sharpton","tweeter_id":"546623315","geo":{"lt":40.25034,"ln":-83.00018,"country":"US"},"followers":1164},"tweet_id":"705324714659614720"},{"url":"http:\/\/twitter.com\/SpaceMedic\/statuses\/705327709891723265","license":"gnip","citation_ids":[6042789],"posted_on":"2016-03-03T09:43:25+00:00","author":{"name":"Space Medic","url":"http:\/\/instagram.com\/spacemedic","image":"https:\/\/pbs.twimg.com\/profile_images\/687232876354519041\/_anQGs4V_normal.jpg","description":"Space, medical and military news by @KrtNthny","id_on_source":"SpaceMedic","tweeter_id":"2289040586","geo":{"lt":37.56826,"ln":126.97783,"country":"KR"},"followers":538},"tweet_id":"705327709891723265"},{"url":"http:\/\/twitter.com\/gedefo_sefh\/statuses\/705446922048421888","license":"gnip","citation_ids":[6042789],"posted_on":"2016-03-03T17:37:07+00:00","author":{"name":"GEDEFO","url":"http:\/\/www.sefh.es","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000753799388\/8561701cfcfbc3a7efa7ec153101b2ab_normal.jpeg","description":"Grupo de Farmacia Oncol\u00f3gica de la SEFH","id_on_source":"gedefo_sefh","tweeter_id":"2184775389","geo":{"lt":39.5,"ln":-3,"country":"ES"},"followers":1989},"tweet_id":"705446922048421888"},{"url":"http:\/\/twitter.com\/FarmaOnco\/statuses\/705487360511877121","license":"gnip","rt":["gedefo_sefh"],"citation_ids":[6042789],"posted_on":"2016-03-03T20:17:48+00:00","author":{"name":"FarmaOnco","image":"https:\/\/pbs.twimg.com\/profile_images\/2930931336\/c5ed1efcf9ddf36d4803c1ab88604f4f_normal.jpeg","description":"Farmac\u00e9utica hospitalaria que intenta mantenerse al d\u00eda en onco, hemato y otras cosas","id_on_source":"FarmaOnco","tweeter_id":"917639060","geo":{"lt":null,"ln":null},"followers":1674},"tweet_id":"705487360511877121"},{"url":"http:\/\/twitter.com\/medicineupdate\/statuses\/708708147506982912","license":"gnip","citation_ids":[6042789],"posted_on":"2016-03-12T17:36:04+00:00","author":{"name":"Tom","url":"http:\/\/j.gs\/1K3w","image":"https:\/\/pbs.twimg.com\/profile_images\/3388626222\/3c70af58befec0257424ebde88c5f261_normal.png","description":"The top 5 internal medicine journals","id_on_source":"medicineupdate","tweeter_id":"174988635","geo":{"lt":null,"ln":null},"followers":3346},"tweet_id":"708708147506982912"},{"url":"http:\/\/twitter.com\/DrChoueiri\/statuses\/710416447357460480","license":"gnip","citation_ids":[6042789],"posted_on":"2016-03-17T10:44:14+00:00","author":{"name":"Toni Choueiri, MD","url":"http:\/\/www.dana-farber.org","image":"https:\/\/pbs.twimg.com\/profile_images\/693093012025561088\/tgX3Norh_normal.jpg","description":"Director, GU Oncology @DanaFarber. Retweets\/\u2764 are not advice\/endorsements #kidneycancer #Harvard #GUcancr #prostatecancer #bladdercancer #ASCO","id_on_source":"DrChoueiri","tweeter_id":"4827883464","geo":{"lt":42.35843,"ln":-71.05977,"country":"US"},"followers":2458},"tweet_id":"710416447357460480"},{"url":"http:\/\/twitter.com\/SMarsh7818\/statuses\/710419392744562688","license":"gnip","citation_ids":[6042789],"posted_on":"2016-03-17T10:55:56+00:00","author":{"name":"Sheryl Marshall","image":"https:\/\/pbs.twimg.com\/profile_images\/832351906844532736\/AHdAmk21_normal.jpg","description":"Working for @C4CBoston & Coyle & Cassidy HS\/MS. Assistant Softball coach for Coyle, worked w\/homeless 10 yrs, issue still close to heart. BIG Red Sox fan!","id_on_source":"SMarsh7818","tweeter_id":"81644173","geo":{"lt":null,"ln":null},"followers":663},"tweet_id":"710419392744562688"},{"url":"http:\/\/twitter.com\/DanaFarber\/statuses\/710470167604686848","license":"gnip","rt":["DrChoueiri"],"citation_ids":[6042789],"posted_on":"2016-03-17T14:17:42+00:00","author":{"name":"Dana-Farber","url":"http:\/\/www.dana-farber.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/859792013218263041\/Upl5i8cH_normal.jpg","description":"Dana-Farber Cancer Institute is a leading center for expert, compassionate cancer care and advanced research. Appointments at: 877-442-3324","id_on_source":"DanaFarber","tweeter_id":"15282064","geo":{"lt":42.35843,"ln":-71.05977,"country":"US"},"followers":66057},"tweet_id":"710470167604686848"},{"url":"http:\/\/twitter.com\/xianmeyer\/statuses\/710539450707795968","license":"gnip","rt":["DrChoueiri"],"citation_ids":[6042789],"posted_on":"2016-03-17T18:53:00+00:00","author":{"name":"Christian Meyer, MD","image":"https:\/\/pbs.twimg.com\/profile_images\/819314175184961539\/4qld-Q7r_normal.jpg","description":"Outcomes and Health Services Research Fellow @CSPH_BWH, Resident in Urology, UKE - Hamburg, @gesru_de NCO to @ESRUrology, views are my own","id_on_source":"xianmeyer","tweeter_id":"2358123805","geo":{"lt":null,"ln":null},"followers":347},"tweet_id":"710539450707795968"},{"url":"http:\/\/twitter.com\/dinasalah255\/statuses\/710744187063427072","license":"gnip","rt":["DrChoueiri"],"citation_ids":[6042789],"posted_on":"2016-03-18T08:26:33+00:00","author":{"name":"Dina Salah","url":"https:\/\/www.facebook.com\/dina.salah.94009","image":"https:\/\/pbs.twimg.com\/profile_images\/884773798406492163\/YVP_BWrR_normal.jpg","description":"Baby oncologist .. \nhttps:\/\/soundcloud.com\/dina-salah-31","id_on_source":"dinasalah255","tweeter_id":"2486302946","geo":{"lt":null,"ln":null},"followers":1401},"tweet_id":"710744187063427072"}]}}